Searched for
PHARMACEUTICAL MARKETING PRACTICES
A roadmap for building future-ready workplacesAs workplaces continue to transform, organizations face the challenge of prioritizing continuous workforce development and skill refinement...- Form panel to curb pharma freebies: SCThe Supreme Court has ordered the government to establish a committee to investigate unethical pharmaceutical marketing. The committee is t...
- Supreme Court seeks committee to curb pharma firms’ unethical marketing practicesThe Supreme Court has directed the government to form a committee regarding pharmaceutical marketing regulations. This follows concerns ove...
- Anupam Rasayan eyes US, Europe pharma push after Bliss deal, one-third revenue from drugsAnupam Rasayan India Ltd anticipates significant growth in its pharmaceutical segment over the next three years. The company expects pharma...
- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsWhat is needed in the markets these days is realism. Not fear or gloom, but a clear-eyed acceptance of where things actually stand. Realism...
- Cancer drug costs Rs 2,700, sells for Rs 27,000: SC questions 10x markup at hospitalsThe Supreme Court has questioned steep markups on cancer drugs and asked the Centre to examine a uniform 16% margin on all medicines. The c...
- From India to the US boardroom: Why L-1A is becoming a strategic US-expansion route for Indian mid-sized businessesIndian mid-sized and entrepreneur-led companies increasingly view the L-1A visa as a means to establish US operations. This visa allows for...
- Forced labour and import: Reading India’s latest foreign trade policy additionsWith this notification in place, India has tried to put a protective layer for the domestic industry from unfair foreign competition.
- India-New Zealand FTA finalised; 100% of Indian exports to get duty-free access from October 20India and New Zealand finalized their free trade agreement, which takes effect October 20. This pact aims to double bilateral trade in good...
- From historical solidarity to strategic trade: The India–South Africa opportunityIndia and South Africa are forging new pathways in trade and investment, showcasing a remarkable growth in bilateral trade. Both nations ar...
- Getaway to the UAE: Delhi roadshow charts India’s next leap into global marketsThe Delhi edition of the Gateway to the UAE Delhi Roadshow, hosted by Ajman Free Zone in partnership with The Economic Times and Times of I...
- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsAs an investor, what you need to do at this point of time is this: A bit of extra work in terms of stock-picking so that you avoid anxiety ...
- World Bank names Nobel laureate Michael Kremer as next chief economistMichael Kremer, the distinguished Nobel laureate, is set to assume the role of chief economist at the World Bank. With a robust background ...
- India-Vietnam defence partnership gets a major push: Joint production of military hardware planned as both nations strengthen Indo-Pacific security tiesIndia and Vietnam are set to strengthen their defence partnership through joint production initiatives while also working to boost bilatera...
- EU-India FTA: European Commission sends landmark trade deal to council for signature, paving way for ratificationThe European Commission has asked EU member states for approval to sign and conclude its landmark Free Trade Agreement with India, a deal t...
- India, Kazakhstan to firm up practical areas of economic cooperation during President Tokayev’s visit for BRICS SummitAs part of the visit for the Summit, President of Kazakhstan Kassym-Jomart Tokayev is scheduled to hold a bilateral meeting with Prime Mini...
- Business outlook 2027: 7 growth opportunities Indian CXOs should watchIndia is entering 2027 with growth opportunities spread across manufacturing, technology, exports, infrastructure, and emerging consumer ma...
- Gland Pharma block deal: Fosun Pharma divests 99 lakh shares worth Rs 2,800 croreFosun Pharma sold a 6% stake in Gland Pharma for ₹2,800 crore via a block deal, reducing its holding to 45.77%. Major buyers included Kotak...
- Block deal alert! Gland Pharma shares fall 3% as 1.2 crore shares change hands in 2 block deals; promoter Fosun likely sellerGland Pharma shares fell after a significant block deal involving Fosun Pharma Industrial. The company's VSEZ facility received zero USFDA ...
- Gland Pharma shares: Promoter Fosun Pharma likely to divest 5% equity worth Rs 2,279 crore via block dealFosun Pharma plans to divest 5% equity in Gland Pharma through a Rs 2,279.5 crore block deal at Rs 2,763 per share. Gland Pharma reported a...
Load More
